HCLTECH shortHCL Technologies (HCLTECH) is exhibiting signs of a potential bearish trend reversal. A clear bearish divergence has formed between price and the Relative Strength Index (RSI), indicating weakening bullish momentum.
Key Observations:
1. Bearish Divergence:
Price has made higher highs, but the RSI has formed lower highs.
This divergence suggests a potential bearish trend reversal.
2. Volume Weakness:
Volume has been declining as the price has increased, indicating waning buying interest.
3. Broken RSI Support:
The stock has broken below a key weekly RSI support level and has retested it, confirming the bearish bias.
Trading Strategy:
Short Entry: Consider shorting HCLTECH around the current price level or a slight pullback to the broken RSI support level.
Stop-Loss: Place a stop-loss order at 1900 on a closing basis to limit potential losses.
Profit Targets:
Target 1: 1700
Target 2: 1540
Target 3: 1420
Community ideas
Is this stock potential? How can we trade? HDFC AMC All of the major index and stocks are trading in bearish structure. Market is potentially discounted and we can look for some buy opportunities.
Looking at HDFC AMC stocks, it is still trading in Bullish structure. For any buy setup we would wait for a Change of structure on lower timeframe , mostly on 15 mins.
Look for MSs on 15min and then we can target the daily recent high as future targets.
Trade safe. This is just for educational purposes.
SUNPHARMA - BREAKOUT RETEST or END of 5th?SUNPHARMA - CMP 1747
It appears that a 5 wave impulse from Covid lows (312) has ended at 1960
Primary and internal counts are marked in the chart
If it is too early to predict/expect a larger retracement of the entire move, lets take one step at a time and look for the price action from May'23 lows.. The 5 wave impulse from 922 to 1960. Even here, the 5 waves are complete and the price is falling/retracing.
Chart is attached here for reference
If we expect a minimum of 50% retracement of this 5 wave impulse, then we are looking at 1440 levels
Worst case, if you look at breakout retest (for those with bullish bias), then a dip down to 1640 cant be ruled out
Price is trading below the cloud and Super trend on Daily TF
Price is trading below all key EMAs.. and 200 EMA is next, placed at 1650 levels.
Definitely not a place to go long..
Daily close above 1800 would be the invalidation level
I am not a SEBI registered Analyst. Views are personal and for educational purpose only. Please consult your Financial Advisor for any investment decisions.
BAJAJ Housing Finance Descending TriangleThird time touched the support trendline
- opens above this trend line stock might go up
- opens below this candle or trend line stock might go down
morning star formed in Descending Triangle bottom which might track the stock to downside
I don't recommend & taking trade based on this idea.
consult your SEBI registered adviser to Know the market risk before trade.
in.tradingview.com/pricing/?share_your_love=johnbritto2088
ESCORTS
The stock is currently approaching its dual support placed between 3340 and 3100 (61.8% FR level & 100 Week EMA).
The Weekly RSI is also coming to its Oversold level.
Past price corrections in this on-going up-move has bottomed out at the 61.8% FR and 100 Week EMA.
The Weekly MACD crossing above its Trigger line would confirm resumption of the up-move.
NIFTY50-pain in short term & reward in long term ....NIFTY50 : 23572.30
NIFTY is in Primary Bull cycle phase (on weekly charts) and in middle of Wave -3, which should take the NIFTY at levels of 33k-43K & finally 55K in next 2 years’ time frame .
On immediate basis (on daily chart basis) chart structure suggest it has entered Intermediate level wave -4 correction. Nifty at its crucial support of 200 Simple Moving Average, and on the weak footing. If nifty doesn’t hold these levels, it will open the downside till 20420 levels . Chart structure suggest that still downside risk is open.
The support levels are listed below
200 SMA placed @23542
S1- 22557; S2-21675; S3- 20420
Currently Nifty is in price correction mode which suggest it to last till Jan 25, and if followed by time corrections, than Fibonacci level suggest the these correction may last till another 2 quarters (Q1 FY25).
DCAL - Potential C&H -Back in Profits. Buy above 215.DCAL is forming Cup & Handle Pattern.
One can enter above 215 with target of 255/400/600/780, with Stop Loss of 171.
Here's a summary of the key points for investors from Dishman Carbogen Amcis Limited's (DCAL) presentation for Q2 FY25:
Financial Highlights
1. Revenue Growth: Net revenue for Q2 FY25 increased by 34.5% YoY to ₹7,890 million, driven by a boost in commercial sales, particularly in the CRAMS (Contract Research and Manufacturing Services) segment in Switzerland and India.
2. Profitability: EBITDA rose significantly to ₹1,485 million with a margin increase from 10.8% in Q2 FY24 to 18.8% in Q2 FY25, due to higher volumes and improved operating margins.
3. Cash Profit: Cash profit for Q2 FY25 stood at ₹1,055 million, almost doubling YoY.
4. Net Debt: The company reported a net debt of CHF 173 million as of September 2024.
5. Capex: H1 FY25 capital expenditure reached approximately USD 15.9 million.
Operational Highlights
1. Revenue Mix:
- CRAMS: Major contributor with 84% of total revenue. Sales grew 51.7% YoY, fueled by increased commercial sales.
- NCE APIs & Intermediates: 6.2% share, with a 36.9% increase in revenue due to growth at the Bavla site in India.
- Cholesterol & Vitamin D Analogues: Decline in sales by 35.7% due to lower margin realization in Cholesterol SF.
- Quats & Generics: Decline due to reduced demand in the agrochemical sector.
2. Capacity Utilization: Focused on improving capacity utilization by targeting small to mid-sized global biotech companies and expanding in new geographies.
Strategic Insights
1. Global Presence: Operations span Switzerland, the UK, France, Netherlands, India, and China, with 28 R&D labs and multi-purpose facilities.
2. Oncology Focus: Oncology, a high-growth therapeutic area, is a priority, with several late-phase oncology molecules in the pipeline.
3. HIPO Facility: The Bavla site in India houses Asia's largest high-potency API (HIPO) facility, positioning DCAL well for growth in oncology.
Industry Overview
- Specialty Medicines Growth: Specialty medicines, which include high-potency oncology drugs, are projected to grow significantly, with an expected 43% share in global pharma spending by 2028.
- Oncology Market: Oncology is projected to grow at a CAGR of 14-17% through 2028, driven by new treatments and demand for potent drugs.
Investment Considerations
2. 1. Strong Revenue and Margin Growth: Consistent revenue growth with enhanced EBITDA margins, indicating improved operational efficiency.
2. Global Expansion & Diversification: Expanding into new geographies and targeting small/mid-size biotech clients mitigates risk and enhances revenue stability.
3. Oncology Focus and HIPO Facility: The HIPO capabilities in India align with the high-growth oncology sector, suggesting long-term growth potential in specialty pharma.
Manappuram Finance Next 1 month SL 1Hr candle close only, Target Trigger Price
All detail for chat. good entry at mark price only. and must stoploss minimum risk and good profit. risk ratio 1:1 to manage modified SL. This is not call, Just my idea. Please understand your risk and take full responsibility of your actions
Reliance Inds cmp 1267.60 by Weekly Chart viewReliance Inds cmp 1267.60 by Weekly Chart view
- Stock has formed Bearish Rounding Bottom
- Support Zone seen at 1050 to 1100 Price Band
- Support Zone 1250 to 1300 Price Band turning into Resistance Zone
- Stock might probably show more downside by the Technical Chart setup
- Weekly Basis : Support at 1195 > 1100 > 995 with Resistance at 1360 > 1445 >1535 > ATH 1608.80
- Stock Price gone well below the crossover of both the Falling Resistance Trendline and also the Rising Support Trendline been broken down
XAU USD ANALYSIS Hello Traders,
CPI News in few Minutes. Today gold was totally sideways. Created lots of liquidity both side. My personal view is 1st market will kick out buyers then gold will be ready for go high. But let's wait for liquidity swip and change of character then we will look for buy 📈
OrderFlow Data Analysis for GOLD { XAUUSD }
Positive Delta formation on rise on daily time frame when the price of gold took a deep downward hit of 150$ steep fall down from 2750 to 2600 . ( the Trump victory Effect ).
Price is struggling to break the 2620 price tag with larger volume. as quoted on my previous candlestick chart analysis, if price breaks 200 ema with larger volume we shall see a buyers rally rushing in and holding the price of 2650 sooner.
Bitcoin Next Target 107,000 USD, Expected Trendline Breakout Bitcoin definitely going to reach the Trendline, so the Target is around 107,000 USD or more. And Expected Breakout above the Trendline.
I want to help People Make Profit all over the World.
My Bitcoin Navigation :
1. Reached 0.5 Fibonacci Retracement.
2. Breakout the Channel Pattern.
3. Reached Channel Top Target.
EUR/USD Slips Amid Strong Downward MomentumThe current downtrend in the EUR/USD pair is evident, with the price testing a critical support level around 1.0550. Over the past few months, EUR/USD has consistently depreciated, largely driven by the strengthening of the USD and unfavorable factors for the Euro. This support level has previously acted as a
From a technical perspective, if this support zone fails to hold, the price is likely to continue its decline towards the next level around 1.0311, according to Fibonacci levels. This is a strong psychological level that could further pressure investors looking to maintain long positions.
Signals from the moving averages also confirm the bearish trend, as these lines are aligned above the price, reinforcing the negative outlook.
Ascending triangle pattern in Ramco CementsChart -> The Ramco Cements Ltd Daily
Textbook based ascending triangle pattern breakout seen with high volumes!
CMP: 900
Good Range To Buy: 875 to 910
Targets: 938, 970, 1015, 1050
SL: 855 Daily Close
Disclaimer: This is for educational purposes only, not any recommendations to buy or sell. As I am not SEBI registered, please consult your financial advisor before taking any action.
Nifty Big fall Ahead Nifty Big correction comming days expecting in daily timeframe it is rejecting founding resistance at 100 ema now it is heading to test 200 ema on daily front in my view it will drop below that so keep checking the levels.
Current Market Sentiment:
Bullish outlook as long as Nifty holds above the 24,000 mark. If 23,800 breaks, a Head and Shoulders pattern may be activated, signaling a potential 10% correction in the coming days.
Key Levels to Watch:
Support Levels:
24,000 – 23,800: This range represents critical support. If Nifty sustains above this level, the bullish trend remains intact.
A break and sustained move below 23,800 could confirm the Head and Shoulders pattern and lead to a deeper fall.
Resistance Levels:
24,300 – 24,550: Recent highs that will act as key resistance.
Breakout above 24,300 could push Nifty towards 24,500 – 24,800 and possibly 25,000.
Breakdown below 23,800 could trigger a correction towards 23,000 or even 21,000, aligning with the pattern’s target.
Head and Shoulders Pattern:
This pattern becomes valid only if Nifty sustains below 23,800. The measured target of the pattern suggests a 10% fall from the breakdown level, which would put Nifty in the range of 21,000 to 22,000.
If Nifty holds above 23,800, the pattern remains invalid and bullish momentum could continue.
PIIND - TOP IS done?PIIND: CMP 4570
It appears that the TOP is done.. 5 wave impulse from 2014 lows of 130 levels seems to be over now..
Chart is attached with counts for easy understanding.
On daily, diagonal is visible..
MACD crossover seen on Weekly TF with Double top/Divergence
On daily, Harmonic Pattern could potentially play out as copied below..
Views are personal and for learning purpose only and not a BUY/SELL recommendation. I am not SEBI Registered.. Please consult your Financial Advisor for investment decision
